The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 10, 2019
Filed:
Mar. 29, 2018
Applicant:
Synta Pharmaceuticals Corp., Lexington, MA (US);
Inventor:
David Proia, Newton, MA (US);
Assignee:
Synta Pharmaceuticals Corporation, Lexington, MA (US);
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/4196 (2006.01); A61K 33/24 (2019.01); A61K 45/06 (2006.01); A61K 31/555 (2006.01); A61K 31/661 (2006.01); A61K 31/675 (2006.01); A61P 35/04 (2006.01); A61K 31/282 (2006.01); A61P 35/00 (2006.01); A61K 31/4184 (2006.01);
U.S. Cl.
CPC ...
A61K 31/4196 (2013.01); A61K 31/555 (2013.01); A61K 31/661 (2013.01); A61K 31/675 (2013.01); A61K 33/24 (2013.01); A61K 45/06 (2013.01); A61K 31/282 (2013.01); A61K 31/4184 (2013.01); A61P 35/00 (2018.01); A61P 35/04 (2018.01);
Abstract
A pharmaceutical combination comprising a platinum-containing anticancer agent, and an Hsp90 inhibitor according to the following formulae (I) & (Ia), a tautomer, or a pharmaceutically acceptable salt thereof, wherein the variables structural formulae are defined herein. Also provided is a method of treating a proliferative disorder such as cancer in a subject in need thereof, using the pharmaceutical combination described herein.